This paper is only available as a PDF. To read, Please Download here.
This community-engaged study examines abortion and family planning doula services, attitudes toward these services, abortion stigma faced by abortion doulas, and doulas’ recommendations to improve access to care.
From October 2020 to February 2022, academic researchers and a community-based maternal-child health organization conducted a cross-sectional, mixed-methods study with full-spectrum doulas in Georgia, where maternal mortality is high but abortion and contraceptive access are restricted. We interviewed and surveyed 20 doulas about their scope of abortion and contraceptive care, their personal attitudes toward family planning, and experiences with abortion stigma.
Our sample was diverse by race/ethnicity (45% Black/African American, 40% White, 5% Latinx, 10% other) and services provided (85% birth, 60% postpartum, 40% full-spectrum, 35% abortion, 45% family planning). Participants reported positive attitudes toward abortion and contraception (Stigmatizing Attitudes and Beliefs=22.29 on an 18–40 scale; adapted Sexual and Reproductive Health Stigma Scale=8.6 on a 6–13 scale). Among abortion doulas, abortion provider stigma was moderate to high (average Abortion Provider Stigma Survey (APSS) score=24 on a 17–27 scale), and resilience was moderate (average resilience score=7 on a 4–11 scale).
This study contributes two main findings: first, family planning and abortion care training are needed and desired by doulas of all kinds. Second, abortion stigma is being experienced by abortion doulas. As contraceptive and abortion care is further restricted, doulas may serve as a vital link to family planning services. Increasing doulas’ capacity to provide contraceptive counseling and abortion care is feasible and imperative.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2022 Published by Elsevier Inc.